<DOC>
	<DOCNO>NCT02678195</DOCNO>
	<brief_summary>This clinical trial evaluate duration treatment chest-indrawing pneumonia child . Half child receive 3 day amoxicillin dispersible tablet ( DT ) 2 day placebo , half receive 5 day amoxicillin DT .</brief_summary>
	<brief_title>3 Days Versus 5 Days Amoxicillin Chest-indrawing Childhood Pneumonia Malawi</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Male female , 2 59 month age . History cough &lt; 14 day difficult breathe chestindrawing . Ability willingness child 's caregiver provide inform consent available followup plan duration study , include accept home visit he/she fail return Kamuzu Central Hospital ( KCH ) schedule study followup visit . If chestindrawing observe screen resolve bronchodilator challenge , among wheeze screening . Severe respiratory distress ( e.g. , grunt , nasal flaring , head nodding , severe chestindrawing ) . Presence World Health Organization ( WHO ) Integrated Management Childhood Illness ( IMCI ) danger sign include : lethargy unconsciousness , convulsion , vomit everything , inability drink breastfeed . Hypoxia ( SaO2 &lt; 90 % room air , assess Lifebox pulse oximeter ) . Stridor calm . HIV1 seropositivity HIV1 exposure , assess follow : An HIVpositive result upon rapid antibody test exclude child study . If child le 12 month age positive rapid test result , child refer receive additional confirmatory HIV testing ( e.g. , dry blood spot filter paper test ) followup KCH staff , per standard care . Even confirmatory HIV test subsequently show child HIVnegative , remain excluded study . If child le 24 month age HIVnegative result upon rapid antibody test , child 's biological mother 's HIV status need assess . If mother HIVpositive , child exclude . If mother document HIVnegative test result within past 6 week , child include . If mother documentation HIVnegative test result , test via rapid antibody test determine child 's eligibility study . If child 24 month age , HIVnegative rapid antibody test require inclusion study . Note : If child documentation HIVnegative test result within past 6 week , test result use child 's eligibility assessment accord algorithm described . Severe acute malnutrition ( i.e. , weight height/length &lt; 3 SD , midupper arm circumference &lt; 115 mm , edema ) . Possible tuberculosis ( cough 14 day ) . Severe anemia , classify WHO pocketbook guideline ( i.e. , severe palmar pallor hemoglobin &lt; 8.0 g/dL ) Severe malaria , classify WHO pocketbook guideline ( e.g. , positive malaria rapid diagnostic test ( mRDT ) danger sign , stiff neck , abnormal bleeding , clinical jaundice , hemoglobinuria ) Known allergy penicillin amoxicillin . Receipt antibiotic treatment 48 hour prior study base caregiver 's selfreport and/or documentation child 's medical record . Hospitalized within 14 day prior study . Living outside Lilongwe urban area , study catchment area . Any medical psychosocial condition circumstance , opinion investigator , would interfere conduct study study participation might jeopardize child 's health . Any nonpneumonia acute medical illness require antibiotic treatment per local standard care . Participation clinical study another investigational product within 12 week prior randomization plan begin participation study . Prior participation Innovative Treatments Pneumonia ( ITIP ) study previous pneumonia diagnosis .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>